Quick Answer
AVANOS MEDICAL, INC. reported Research And Development Expense of $23.30 million for the year ending 2025.
- AVANOS MEDICAL, INC. showed a decrease of -11.1% in Research And Development Expense from 2024 to 2025.
- This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), AVANOS MEDICAL, INC.'s Research And Development Expense has declined by 29.4%.
- Historical annual values: Fiscal year 2025: $23.30 million | Fiscal year 2024: $26.20 million | Fiscal year 2023: $27.20 million | Fiscal year 2022: $29.20 million | Fiscal year 2021: $30.60 million | Fiscal year 2020: $34.90 million | Fiscal year 2019: $37.70 million | Fiscal year 2018: $41.80 million | Fiscal year 2017: $38.20 million | Fiscal year 2016: $38.40 million | Fiscal year 2015: $27.60 million | Fiscal year 2014: $33.60 million | Fiscal year 2013: $37.90 million | Fiscal year 2012: $33.00 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: